Producer

Roquette Frères S.A.

HQ FR · Hauts-de-Francewebsite ↗

French family-owned starch and pharmaceutical excipients company; pioneered pharmaceutical-grade parenteral dextrose ~40 years ago; brand: Lycadex PF (pyrogen-free dextrose monohydrate for IV/PD solutions); operates new GMP injectable carbohydrate facility at Lestrem, France; supplies global PD solution and parenteral nutrition manufacturers; one of the largest pharmaceutical starch/glucose suppliers in Europe

3

Inputs supplied

2

Goods downstream

3

Facilities

0

Stories

Where it shows up

Goods downstream

Essential goods that depend on something Roquette Frères S.A. makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Pharmaceutical Excipients & Parenteral

    35%
  • Food & Nutrition Ingredients

    30%
  • Industrial Starches & Sweeteners

    25%
  • Animal Nutrition

    10%

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Origin2018

    Roquette pioneered pharmaceutical-grade parenteral dextrose powder approximately 40 years ago (circa 1985), enabling modern large-volume parenteral (LVP) solution manufacturing to shift from glucose solutions prepared fresh in hospital pharmacies to centrally manufactured, commercially sterile PD and IV solutions. Roquette's Lycadex PF (pyrogen-free dextrose monohydrate) is used worldwide by PD solution manufacturers as the primary osmotic agent. The Lestrem facility is the largest starch-processing complex in Europe and represents the concentrated European production location for pharmaceutical dextrose.

    Manufacturing Chemist